SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

25-Aug-2016 - Grunenthal has reiterated the benefits of its anti-crush intac tech after licensee Endo withdrew its request to have Opana ER labelled as “abuse deterrent."

US FDA wants to reclassify co-crystals to ease regulatory burden

18-Aug-2016 - The US FDA wants to reclassify pharmaceutical co-crystals as solvates rather than intermediates to reduce the regulatory burden on manufacturers that work with them.

Public Patheon's $2bn warchest may bolster biologics offering, analyst

17-Aug-2016 - Biomanufacturing demand will drive revenues for Patheon according to an Evercore ISI analyst, who has predicted the newly-listed CDMO will strengthen its capabilities through M&A.

Valeant gives six months timeline for FL plant reinspection after eye drug CRL

11-Aug-2016 - Concerns raised by the US FDA pertaining to cGMP at a Florida facility are expected to be resolved within six months, according to Valeant.

Catalent wins early-phase contract for Arch's inhaled orphan drug

11-Aug-2016 - Arch Biopartners has selected Catalent to carry out studies and make batches of its orphan drug candidate AB569 for upcoming clinical trials.

Acino agrees to sell drug delivery patch business to Luye Pharma for $274m

02-Aug-2016 - Acino has agreed to sell its transdermal delivery patch business Luye Pharma Group in a deal that will include its manufacturing site in Miesbach, Germany.

West: Amgen mAb approval helps validate drug delivery tech

01-Aug-2016 - Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.

Saneca inks Eastern Europe manufacturing and registration deal with Xantis

27-Jul-2016 - Slovakian CDMO Saneca Pharma will make more than 20 generic products for Xantis after selling the registration dossiers to the Swiss firm.

GSK commits to UK manufacturing with £275m investments across three sites

27-Jul-2016 - GSK will pump £275m ($360m) into its UK manufacturing network and says the country has a “leading position in life sciences” despite the recent Brexit vote.

US FDA won't OK eye pain candidate until Ocular Therapeutix addresses production concerns

26-Jul-2016 - The US FDA will not approve the candidate eye pain eye treatment Dextenza until developer Ocular Therapeutix addresses concerns about how the product is made. 

Roche getting under the skin of biosimilar competition

25-Jul-2016 - Subcutaneous versions of its biologic blockbusters - including Mabthera and Herceptin - will help protect against biosimilar competition, says Roche.

Evonik to buy CDMO for drug delivery technologies

19-Jul-2016 - Evonik has bought Transferra Nanosciences to expand its injectable drug delivery technology offering.

World bank will loan B. Braun $33m for Indonesia injectables plant

18-Jul-2016 - The World Bank has confirmed it will loan B. Braun $33m (€30m) to help pay for a manufacturing facility in Indonesia.

MonoSol Rx licenses film tech to Kuraray-owned namesake for non-pharma uses

18-Jul-2016 - MonoSol Rx licenses delivery film tech to MonoSol LLC for non-pharma uses.

Pharmacy researchers work to improve drug delivery

14-Jul-2016 - Researchers suggest targeted nanosystem drug delivery could be the key to crossing gastrointestinal tract and blood-brain barriers – a prevailing issue with oral medications.

Astellas to develop rice-based oral cholera vaccine

06-Jul-2016 - Japan's Astellas has agreed to carry out clinical trials of a vaccine for serious diarrhoeal diseases which does not need to be refrigerated or injected and is produced in transgenic rice plants.

Silk rockets and 3D printing: Researchers looks to transform drug delivery

30-Jun-2016 - Engineers from the University of Sheffield have developed 3D-printed silk 'micro-rockets' they say could be used to improve drug delivery.

Magnetically controlled drug dissolves blood clots with fewer side effects

27-Jun-2016 - Researchers have developed a new magnetically controlled drug that can dissolve clots up to 4,000 times more efficiently than ordinary enzyme-based drugs.

Opko extended-release kidney disease drug approved after Catalent 483 delay

22-Jun-2016 - The US FDA has approved Opko Health’s kidney disease drug Rayaldee, delayed by almost three months due to manufacturing concerns at its CMO Catalent.

Collegium's OxyContin rival is first drug using Deterx anti-abuse tech launched in US

21-Jun-2016 - Collegium Pharmaceutical has launched the first product formulated using its Deterx anti-abuse technology in the US.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation